Summary: The purpose of this study was to examine the re lation between glucose metabolism and glutamate concentra tion in the human brain, in both the normal and diseased state. Regional values of glucose metabolism measured with 2-de oxy-2[F-18lt1uoro-D-glucose positron emission tomography (FDG PET) studies and single-voxel proton magnetic reso nance spectroscopy (I H MRS) measurements of the glutamate/ glutaminely-aminobutyric acid (Glx) tissue concentration were determined in multiple brain regions in II patients (5 girls and 6 boys, mean age 7.5 years) with medically intractable partial epilepsy. FDG PET and IH MRS studies were performed in the interictal state in seven patients and in the ictal/peri ictal state in four patients. Regions of interest were identified in epileptic cortex (determined by intracranial and/or scalp electroencepha lography) and in contralateral normal brain regions. Lower
Glutamate is the main excitatory neurotransmitter in the human brain and is believed to play an important role in the initiation, spread, and maintenance of epilep tic activity (Meldrum, 1992) . Glutamate receptors are located on glial and neuronal cells (Chapman, 1998; Stephens et aI., 1993) . Increases in the density of N methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA), and kainate glucose metabolism and lower Glx concentrations were found in the epileptic focus than in the contralateral normal cortex in all seven patients examined in the interictal state, whereas higher glucose metabolism and higher Glx concentrations were observed in the epileptic focus in the four patients who had ictal/peri ictal studies. Significant correlations were found be tween the values of cerebral glucose utilization and Glx con centration in epileptic brain region, in nonepileptic brain re gions, and in epileptic and nonepileptic regions combined. These results demonstrate a significant relation between glu cose metabolism and glutamate/glutamine concentration in nor mal and epileptic cerebral cortex. This relation is maintained in both the interictal and ictal states. Key Words: Epilepsy Glucose metabolism-Glutamate-Positron emission tomogra phy-Proton magnetic resonance spectroscopy.
receptors (Brines et aI., 1997; Geddes et aI., 1990; Hos ford et a\., 1991) , and an increased number of glutamate receptor subunits have been described in epilepsy (Math ern et aI., 1997 (Math ern et aI., , 1998 . The functions of glutamate metabotropic and NMDA receptors are modified in epi lepsy (Akiyama et aI., 1992; AI-Ghoul et aI., 1997; Dietrich et aI., 1999; Ehlers et aI., 1996) , and alterations in glutamate transporters also potentially can contribute to epileptogenesis (Akbar et aI., 1997; Mathern et aI., 1999; Tanaka et aI., 1997) .
There have been attempts to develop glutamate recep tor tracers for in vivo functional imaging studies in hu mans. For example, (+)-3-[I-123]Iodo-MK-801 has been developed for imaging with single photon emission com puted tomography (SPECT) (Owens et aI., 1997) , and (+ )-3-[C-ll ]cyano-dizocilpine has been synthesized as a radiotracer for positron emission tomography (PET) (Sihver et al., 1998) for the in vivo assessment of NMDA receptors. However, further development of these and other potential ligands is still required.
A recently articulated hypothesis suggests that most of the signal derived from 2-deoxy-2[F-18]fluoro-glucose (FDG) uptake measured with PET is due to glutamate stimulation of glucose uptake by astrocytes (Magistretti et aI., 1999; Magistretti and Pellerin, 1996) . If this hy pothesis is correct, the numerous FDG PET studies on patients with epilepsy in the literature might be reinter preted in terms of glutamate neurotransmitter activity. The hypothesis regarding glutamate and glucose cou pling is based on the observation that glutamate stimu lated 2-deoxyglucose uptake and phosphorylation by as trocytes in primary culture (Magistretti et aI., 1999; Mag istretti and Pellerin, 1996) . Glutamate uptake into the astrocytes by a glutamate transporter resulted in a con comitant stimulation of glucose uptake by means of a mechanism involving activation of the Na + /K + ATPase, followed by an increase in lactate efflux from the astro cytes (Pellerin and Magistretti, 1994) . Thus, Pellerin and Magistretti (1994) have proposed that this mechanism accounts for the coupling between neuronal activity and energy metabolism. Further data in support of this theory are derived from [C-13] magnetic resonance spectros copy (MRS) studies in which cortical rates of oxidative glucose metabolism and glutamate neurotransmitter cy cling were measured in rats under different degrees of anesthesia (Sibson et aI., 1998) . Sibson et aI. estimated an approximately 1: I stoichiometry between glutamate cycling and glucose metabolism, with glutamatergic syn aptic activity accounting for more than 80% of total glu cose oxidation under conditions of mild anesthesia. The magnitude of the stoichiometry reported between gluta mate cycling is surprising when one considers the nu merous other metabolic requirements for glucose, and this issue remains controversial in the neuroscience field. Most of the data supporting this hypothesis, however, were derived either from cultured astrocytes or anesthetized rodents, and therefore the applicability of these findings to humans remains to be established. Toward this goal, Gruetter et aI. (1998) The purpose of this study was to test the hypothesis of coupling between glutamate and glucose metabolism in humans with epilepsy by comparing regional values of glucose metabolism from FDG PET studies with I H MRS measurements of the glutamate/glutaminei'y aminobutyric acid (Glx) tissue concentration (Duncan, 1996; Frahm and Hanefeld, 1996; Moore, 1998) . Com parisons of glucose utilization and glutamate/glutamine concentrations in patients with focal epilepsy allows measurements in the unstimulated interictal state and, in a few subjects, the stimulated ictal/periictal state, for both epileptic and normal cortex.
METHODS

Subjects
Eleven patients (5 girls and 6 boys, mean age 7.5 years, age range 0.3 to 20 years) with medically intractable partial epi lepsy were included in the study ( MRI, magnetic resonance imaging; PET, positron emission tomography; FDG, 2-deoxy-2[F-181tluoro-glucose; CP, complex partial; SP, simplex partial; GTC, generalized tonic-clonic; IS, infantile spasm; L, left; R, right; T, temporal; F, frontal; P, parietal; 0, occipital; med, medial; lat, lateral; ant, anterior; sup, superior; inf, inferior; mts, medial temporal sclerosis; dysplas, dysplasia; wmasi, white matter abnormal signal intensity; scizenc, scizencephaly; thaI, thalamus; cbel, cerebellum; pcing, posterior cingulate; >, more prominent side of spiking; 1., decreased metabolism; I, increased metabolism; *, confirmed by electrocorticography; ND, not done, this patient did not have surgery.
mono-or poly therapy with carbamazepine (n = 3), clonaze pam (n = 2), felbamate (n = I), gabapentin (n = 2), la motrigine (n = 2), phenobarbital (n = 1), phenytoin (n = 3), valproate (n = 7), and vigabatrin (n = 2). Studies were per formed in accordance with the regulations of the Human In vestigation Committee at Wayne State University.
PET scanning protocol
Patients fasted for 4 hours before the PET studies. Scalp EEG electrodes were placed according to the International 10-20 System, and the EEG was monitored throughout the tracer uptake period. A venous line was established for injection of FDG (0.143 mCilkg) produced using a Siemens RDS-I I cy clotron (Knoxville, TN, U.S.A.). External stimuli were mini mized by dimming the lights and discouraging interaction so that studies reHected the resting awake state during the uptake period (0 to 30 minutes after injection). Sedation with intrave nous nembutal or midazolam was used if necessary only after the tracer uptake period.
FDG PET studies were performed using a CTIISiemens EX ACT/HR whole-body positron tomograph (Siemens). This scanner has a 15-cm field of view and generates 47 image planes with a slice thickness of 3.125 mm. The reconstructed image in-plane resolution obtained is 6.5 ± 0.35 mm at full width at half maximum and 6.0 ± 0.49 mm in the axial direction for the FDG PET (reconstruction parameters: Shepp-Logan fil ter with 1.1 cycles/cm cutoff frequency and Hanning filter with 0.20 cycles/pixel cutoff frequency). Calculated attenuation cor rection was performed as previously described (Bergstrom et a!., 1982) .
MRIIMRS protocol
MRI and MRS examinations were performed on a GE 1.5 Tesla Signa 5.7 unit (GE Medical Systems, Milwaukee, WI, U.S.A.). Multiplanar MRI sequences were obtained in all cases, including a I 24-slice (1.5-mm thickness) Tl-weighted spoiled gradient echo (SPGR) sequence and a 21-plane axial T2-weighted sequence. Sedation with intravenous nembutal or midazolam was used if necessary.
During the IH MRS exarriination, a stimulated echo acqui sition mode (STEAM) pulse sequence (Frahm et a!., 1987) was used to acquire spectra using the following acquisition param eters, which also included unsuppressed water reference scans for neurochemical quantitation: echo time = 30 milliseconds, modulation time = 13.7 milliseconds, repetition time = 2 seconds, 8-step phase cycle, 2,048 points, spectral width = 2,500 Hz, and 128 averages for a total acquisition time of approximately 5 minutes. In vivo spectra were acquired from approximately 8-cc regions of interest (ROIs) in the region of the seizure focus and symmetrically on the contralateral side such that they contained almost entirely gray matter and did not contain structural lesions, if present.
MRIIPET coregistration
Coregistration of FDG PET and MRI image volumes was performed as described previously, using a multipurpose three dimensional registration technique (MPItool) developed by the Max Planck Institute in Cologne, Germany (Pietrzyk et aI., 1990 (Pietrzyk et aI., , 1994 . The PET image volume was coregistered with the axial MRI volume using MPItool, and a new image volume was created with 21 image planes corresponding to the original MRI planes. Brain ROIs for the position of the MRS voxel were registered on the axial T2-weighted MRIs and then trans ferred to the coregistered FDG PET images.
PET image analysis
Regional values for tracer concentration were obtained by taking the average value for all planes in which the voxel was located. Regional values were then normalized to the concen tration for the normal hemisphere (contralateral to the seizure focus), yielding a ratio of relative regional cerebral glucose utilization (rCGU). For the assessment of asymmetries in glu cose metabolism, we used an asymmetry index (AI):
where Al and Ac are the radioactivity concentrations (fLCilmL) for the defined brain regions on the side of the seizure focus and contralateral to the focus, respectively.
Quantitative MRS analysis
The Glx complex was identified in short-echo IH MRS. The area under each of the resonances is proportional to the con centration of the specific neurochemical compound. Individual peak areas were fit using time domain analysis software (de Beer et a!., 1992; van den Boogaart et aI., 1994) , and the concentrations of each compound are reported in arbitrary quantitative units as a ratio to brain water concentration (x 104/ water). This water referencing method has been used in the field for more than a decade and has been validated by several research groups (Barker et aI., 1993; Christiansen et aI., 1993; Frahm et aI., 1990; Hennig et aI., 1992; Hetherington et aI., 1996; Klose, 1990; Soher et aI., 1996; Thulborn and Acker mann, 1983) . The analysis software is public domain (http:// www.mrui.uaiJ.es/mruiHomePage.html) and eliminates much of the subjectivity previously involved in determining spectral peak areas using older methods. The software performs an automated fit of the unsuppressed water peak to determine its peak area and also uses the phase of the water peak to apply an automated zero-order phase correction to the metabolite data. After this, the user enters a priori information regarding the neurochemical data to give the software starting values for its fitting process. The a priori information given includes the expected chemical shifts for each of the major chemical com pounds appearing in the typical proton brain spectrum, as well as a starting Iinewidth, determined by the corresponding water linewidth. The chemical shift value for the Glx complex based on literature values is 2.3 (Barker et aI., 1994; Frahm et aI., 1989; Kreis et aI., 1993; Michaelis et aI., 1993; Narayana et aI., 1989) . The Glx resonance typically contains approximately equal amounts of glutamine and glutamate, with a broader un derlying macromolecule component and a relatively small con tribution from 'Y-amino-butyric acid (GABA). However, with the acquisition parameters used in this study (TE = 30 milli seconds PRESS sequence), the relative MR visibility of neu rochemicals in the Glx resonance is more heavily weighted toward glutamate than glutamine because of relaxation and modulation effects (conservatively, a 60-to-40 ratio, assuming equal concentrations).
Statistical analysis
Statistical analysis was performed using StatView statistical package (BrainPower, Inc., Calabasas, CA, U.S.A.). Pearson's correlation was used to assess the correlation between the ab solute values for Glx and relative rCGU values. The statistical significance of the correlations was calculated using an F test. P < 0.05 was considered to be significant.
RESULTS
Analysis of rCOU for the region of the seizure focus showed a broad range of values, varying from a decrease of 23.8% to an increase of 16.9% compared with the contralateral homotopic normal region (Table 2) . De creased glucose metabolism was found in the seizure Glx. glutamate/glutamine/-y-aminobutyric acid; rGCU, regional cerebral glucose utilization; FDG PET, 2-de oxy-2lF-181fluoro-glucose positron emission tomography; AI, asymmetry indices. Glx values in arbitrary units (xI04/water). Side of EEG focus is sct in boldface type.
focus (as determined by intracranial and/or scalp EEG) in all seven patients examined in the interictal state (see Table 2 , patients I to 7; Fig. IA) , whereas increased metabolism was observed in the four patients who had ictal studies (see Table 2 , patients 8 to 11; see Fig. 1B ).
A summary of the qualitative (visual) assessment of glu cose metabolism abnormalities is presented in Table I . Quantitative values of rCGU in the epileptic focus and contralateral homotopic regions are given in Table 2 .
Similarly, decreased Glx concentration on the side of the epileptic focus relative to the contralateral side was found in all patients with interictal studies (see Table 2 , Fig. 2A ). In patients with ictal/periictal studies, there were higher Glx concentrations on the side of the EEG focus (see Table 2 , Fig. 2B ). NA, N-acetyl compounds; Cr, creatine/ phosphocreatine; Cho, choline; ml, myo-inositoi.
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gray matter. Thus, we have attempted to identify vol umes of interest that contain predominantly cortical gray matter. In normal tissue, the ratio of glutamate/glutamine measured with ' H MRS in gray versus white matter is approximately 1.5 (Frahm and Hanefeld, 1996) . Al though the ratio of 1.5 is less than the reported 1.9 ratio for parietal gray/white matter glucose utilization mea sured with FDG PET (Mazziotta et aI., 198 1) , the vol umes of interest used for MRS studies contain more NA "spillover" of white matter into gray matter and vice versa than typical ROIs drawn on PET scans.
By combining FDG PET with ' H MRS, it is possible to study the relation between cortical glucose metabo lism and glutamate/glutamine concentration in humans under normal and pathologic conditions. Using this ap proach, we have found a significant positive linear cor relation between cortical rCGU and the glutamate/gluta mine concentration, both for the epileptic focus and for the contralateral homotopic cortex. In ROIs containing 'the epileptic focus, interictal glucose hypometabolism was associated with decreased Glx concentration, whereas ictal/periictal increased glucose metabolism was related to increased Glx concentration. This finding is consistent with the hypothesis suggesting a relation be tween glutamate cycling and glucose metabolism. Several methodologic limitations of our study should be addressed. First, although both FDG PET and I H MRS studies for a given patient were obtained in the same state (ictal or interictal), these were not obtained simultaneously. We have attempted to match the condi tions between the two series, but even then the EEGs between the two scans almost certainly will be different. Second, the Glx resonance contains not only glutamate but also glutamine (approximately 40% of the peak), a broad underlying macromolecule component, and a small contribution from GABA. Thus, it is possible that the changes in Glx measured represent changes in glu tamine rather than, or in addition to, changes in gluta mate. Further, the Glx peak contains the enti{e tissue glutamate/glutamine pool, of which the released gluta mate is only a small component (Sibson et aI., 1998) . Measurement of metaboli . c pools alone cannot be used to infer the activity of a metabolic reaction.
Enhanced glutamate release, contributing to the initia tion of seizure activity, has been reported in microdialy sis studies during seizures in patients with partial epi lepsy (During and Spencer, 1993; Meldrum, 1993; Ronne-Engstrom et aI., 1992) , as well as in some animal models (Jarvie et aI., 1990; Minamoto et aI., 1992 focal epilepsy (Fazekas et aI., 1995) . A lower Glx con centration has been shown ipsilateral to the seizure onset in patients with temporal lobe epilepsy and hippocampal sclerosis compared with normal controls (W oermann et aI., 1999) . These data suggest that the Glx concentration is lower in epileptogenic brain regions than in normal tissue, but it may increase with ictal activity.
Our data showing an increased Glx concentration with seizure activity are consistent with results of previous studies. The mechanism for a rapid increase in total tis sue Glx during seizure activity, however, is unclear. We speculate that the increase may be the result of increased flux through the glutamate/glutamine synthesis cycle. Another possible mechanism that might contribute to a rapid increase in total tissue glutamate could be the re lease of glutamate through the cleavage of n-acetyl aspartylglutamate (NAAG) (Coyle, 1997) . NAAG is a neuropeptide that is released by neuronal depolarization and is converted to N-acetyl-aspartate (NAA) and gluta mate by glutamate carboxypeptidase II (Coyle, 1997) , an enzyme present on the extracellular surface of glia and neurons (Cassidy and Neale, 1993) . Alterations in NAAG and the carboxypeptidase activity have been re ported in several animal models of epilepsy. In geneti cally epilepsy-prone rats, the activity of this membrane bound enzyme (Robinson et aI., 1987) is increased in several brain regions, which increases the availability of NAA and glutamate in certain synapses of the brain (Meyerhoff et aI., 1992) . A kindling-induced increased NAAG level was observed in the entorhinal cortex (Meyerhoff et aI., 1989) . Further, the rapid turnover of NAAG shows that the conversion of NAA to NAAG can be an important modulator of synaptic activity (Tyson and Sutherland, 1998) . However, NAAG concentrations are too small to account for the entire change in Glx measured in the present study. Nonetheless, it is possible that alteration of the synthesis, release, and catabolism of NAAG under certain conditions may play a role in the generation of epileptic activity.
In conclusion, our results demonstrate a significant relation between the tissue glutamate/glutamine concen tration and glucose metabolism in human cortex. How ever, our data are correlational and cannot be used to support or refute the magnitude of the relation as previ ously described in animals (Sibson et aI., 1998) . These data add to the growing body of literature supporting the relation of glutamate metabolism to glucose metabolism in the cerebral cortex, and extend previous findings to humans with epilepsy.
